Sevo Nutraceuticals


Overview

Sevo brings science-based products to market, filling a need for products with supportable claims. Percepta, Sevo’s first product, is the result of 15 years of research and has been shown to reduce symptoms of dementia and improve cognition in healthy adults. Benefits include cost savings associated with reduced levels of care for Alzheimer's patients and allowing aging baby boomers to maintain mental acuity as they age.

Management Team

CEO

Bernie Prusaczyk

Experienced entrepreneur with over 25 years’ experience in leadership, sales, marketing and business development. At core of several start-ups, managing from pre-revenue through rapid revenue and exit. Grew Agfa division (now Monotype Imaging) from <$2MM to > $30MM. Grew NuGenesis Technologies from $0 to $25MM and successful sale to Waters Corporation.

Jules Fried